BioPharma Dive
The biotech will use the proceeds to develop inhalable versions of therapies already on the market for the idiopathic and progressive forms of pulmonary fibrosis.
BioPharma Dive
The biotech will use the proceeds to develop inhalable versions of therapies already on the market for the idiopathic and progressive forms of pulmonary fibrosis.
BioPharma Dive
The biotech will use the proceeds to develop inhalable versions of therapies already on the market for the idiopathic and progressive forms of pulmonary fibrosis.